Hong Kong stocks are moving differently. Concept stocks of innovative drugs rose today. The National Medical Products Administration released its annual clinical drug report. New policies support foreign investment in the development of pharmaceuticals.

According to the Securities Times APP, concept stocks of innovative drugs rose today. As of the time of this report, Shisanyao Group (02005.HK) rose 6.93% to 2.16 Hong Kong dollars; Kangnaoy-B (02162.HK) rose 4.14% to 59.05 Hong Kong dollars; Hengrui Medicine (01276.HK) rose 3.55% to 56.9 Hong Kong dollars; Kangfang Biotechnology (09926) rose 2.23% to 84.8 Hong Kong dollars; Xinda Biotechnology (01801) rose 1.86% to 76.75 Hong Kong dollars.